ROS1-话题@MedSci

#ROS1#

26篇内容 | 1343人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1533952, encodeId=a42f1533952fd, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）, objectType=article, longId=76572, objectId=8bfbe657216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfbe657216, replyNumber=0, likeNumber=37, createdTime=2016-09-04, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfbe657216, moduleTitle=精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bfbe657216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533951, encodeId=db8f153395136, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=ASCO 2016 巅峰对话：吴一龙、Alice Shaw解析ALK、ROS1、MET 14外显子跳跃突变研究进展, objectType=article, longId=70428, objectId=5961e042874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5961e042874, replyNumber=0, likeNumber=46, createdTime=2016-06-12, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5961e042874, moduleTitle=ASCO 2016 巅峰对话：吴一龙、Alice Shaw解析ALK、ROS1、MET 14外显子跳跃突变研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5961e042874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533950, encodeId=4d531533950db, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=KIT突变致ROS1阳性肺癌对克唑替尼耐药, objectType=article, longId=66750, objectId=265c66e50ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=265c66e50ea, replyNumber=0, likeNumber=54, createdTime=2016-04-20, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=265c66e50ea, moduleTitle=KIT突变致ROS1阳性肺癌对克唑替尼耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=265c66e50ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533949, encodeId=1fbf153394912, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=生物标志物驱动精准医疗的又一典范：FDA批准辉瑞抗癌药Xalkori治疗ROS1阳性非小细胞肺癌, objectType=article, longId=64856, objectId=125f6485664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125f6485664, replyNumber=0, likeNumber=40, createdTime=2016-03-17, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125f6485664, moduleTitle=生物标志物驱动精准医疗的又一典范：FDA批准辉瑞抗癌药Xalkori治疗ROS1阳性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125f6485664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533948, encodeId=12081533948fc, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=NEJM：ROS1靶点仅占肺癌的1% 却十分重要, objectType=article, longId=43202, objectId=99d54320251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99d54320251, replyNumber=0, likeNumber=38, createdTime=2014-11-28, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99d54320251, moduleTitle=NEJM：ROS1靶点仅占肺癌的1% 却十分重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99d54320251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533947, encodeId=3ef9153394ee0, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展, objectType=article, longId=41397, objectId=a5934139eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5934139eb6, replyNumber=0, likeNumber=25, createdTime=2014-10-19, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5934139eb6, moduleTitle=ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5934139eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533946, encodeId=8b6715339468b, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=NEJM：克唑替尼对ROS1基因重排的非小细胞肺癌患者具有显著的抗肿瘤作用, objectType=article, longId=40739, objectId=93a940e39d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93a940e39d7, replyNumber=0, likeNumber=40, createdTime=2014-09-29, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93a940e39d7, moduleTitle=NEJM：克唑替尼对ROS1基因重排的非小细胞肺癌患者具有显著的抗肿瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93a940e39d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533945, encodeId=25f6153394501, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=JTO:ROS1基因重排的肺腺癌粟粒状脑转移一例, objectType=article, longId=35035, objectId=16e335035c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e335035c4, replyNumber=0, likeNumber=48, createdTime=2014-05-22, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e335035c4, moduleTitle=JTO:ROS1基因重排的肺腺癌粟粒状脑转移一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e335035c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533944, encodeId=8c8b153394405, content=<a href='/topic/show?id=0717156309a' target=_blank style='color:#2F92EE;'>#ROS1#</a>, objectTitle=Mol Cancer Res : 肺癌与大肠癌共享致癌基因ALK和ROS1, objectType=article, longId=28545, objectId=fbc0285451b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbc0285451b, replyNumber=0, likeNumber=35, createdTime=2013-12-27, rootId=0, userName=wwzzly, userId=2f0712501452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbc0285451b, moduleTitle=Mol Cancer Res : 肺癌与大肠癌共享致癌基因ALK和ROS1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbc0285451b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ROS1

2020-05-29

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）

2016-09-04

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

ASCO 2016 巅峰对话：吴一龙、Alice Shaw解析ALK、ROS1、MET 14外显子跳跃突变研究进展

2016-06-12

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

KIT突变致ROS1阳性肺癌对克唑替尼耐药

2016-04-20

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

生物标志物驱动精准医疗的又一典范：FDA批准辉瑞抗癌药Xalkori治疗ROS1阳性非小细胞肺癌

2016-03-17

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

NEJM：ROS1靶点仅占肺癌的1% 却十分重要

2014-11-28

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

ESMO 2014：克唑替尼可有效抑制ROS1阳性非小细胞肺癌的进展

2014-10-19

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

NEJM：克唑替尼对ROS1基因重排的非小细胞肺癌患者具有显著的抗肿瘤作用

2014-09-29

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

JTO:ROS1基因重排的肺腺癌粟粒状脑转移一例

2014-05-22

wwzzly (审核中...)

前往app查看评论内容

#ROS1#

Mol Cancer Res : 肺癌与大肠癌共享致癌基因ALK和ROS1

2013-12-27

科室
- - 订阅+
  - 更多科室
工具
服务